Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA 510(k) approval for EndoSonics:

This article was originally published in Clinica

Executive Summary

The FDA has awarded 510(k) marketing clearance to EndoSonics' FloWire 300 and FloWire 300XT Doppler guide wires. Both models are designed to enable catheter exchanges during cardiovascular intervention, allowing stent deployment and alternative balloon therapies. Physicians can begin a procedure with one catheter and then switch to a different catheter or stent during the procedure without removing the FloWire. The wires are for use in conjunction with the Cardiometrics FloMap Functional Assessment products.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT086797

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel